{
  "nctId": "NCT03513757",
  "briefTitle": "Dexmedetomidine and Propofol for Pediatric MRI Sedation",
  "officialTitle": "An Observer-blinded Randomized Study of Propofol Infusion vs Bolus Dexmedetomidine and Propofol Sedation for Pediatric Magnetic Resonance Imaging",
  "protocolDocument": {
    "nctId": "NCT03513757",
    "filename": "Prot_SAP_001.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2019-10-19",
    "uploadDate": "2020-02-19T09:08",
    "size": 369997,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03513757/document/Prot_SAP_001.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE4"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "TRIPLE",
  "enrollmentInfo": {
    "enrollmentCount": 40,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2018-03-04",
    "completionDate": "2018-10-21",
    "primaryCompletionDate": "2018-08-21",
    "firstSubmitDate": "2018-02-04",
    "firstPostDate": "2018-05-02"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* All children scheduled for outpatient MRI scans with expected duration of scan between 30 minutes and 75 minutes.\n\nExclusion Criteria:\n\n* Inpatient status, airway abnormalities, allergy to any study medications, eggs and soy, and mitochondrial disorders.\n* All subjects with any cardiac disease or history of cardiac arrhythmias will be excluded.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "12 Months",
    "maximumAge": "60 Months",
    "stdAges": [
      "CHILD"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Efficiency of Propofol Dexmedetomidine Sedation Compared With Propofol Infusion",
        "description": "Time (minutes) from anesthesia start to readiness for discharge from the department to home or clinic.",
        "timeFrame": "through study completion, an average of 2 hours"
      }
    ],
    "secondary": [
      {
        "measure": "Total Propofol Administered",
        "description": "total propofol administered (mg/kg)",
        "timeFrame": "up to 90 minutes"
      },
      {
        "measure": "Dexmedetomidine Dose",
        "description": "dexmedetomidine dose (mcg/kg)",
        "timeFrame": "up to 90 minutes"
      },
      {
        "measure": "Glycopyrrolate Dose",
        "description": "glycopyrrolate dose (mcg/kg)",
        "timeFrame": "5 minutes"
      },
      {
        "measure": "Lidocaine Dose",
        "description": "lidocaine dose (mg/kg)",
        "timeFrame": "up to 90 minutes"
      },
      {
        "measure": "Nitrous Oxide",
        "description": "documentation of use",
        "timeFrame": "up to 10 minutes"
      },
      {
        "measure": "Sevoflurane",
        "description": "sevoflurane induction time of 5 minutes",
        "timeFrame": "sevoflurane induction time up to 10 minutes"
      },
      {
        "measure": "Eye Opening",
        "description": "minutes from completion of scan to spontaneous eye opening",
        "timeFrame": "up to 90 minutes"
      },
      {
        "measure": "Oral/Enteral Intake",
        "description": "minutes from completion of scan to oral/enteral intake",
        "timeFrame": "up to 2 hours"
      },
      {
        "measure": "Discharge Ready",
        "description": "minutes from completion of scan to discharge ready",
        "timeFrame": "up to 2 hours"
      },
      {
        "measure": "Sleep Pattern",
        "description": "parental observation of deviation from child's normal habit obtained through follow-up phone call",
        "timeFrame": "up to 48 hours"
      },
      {
        "measure": "Irritability",
        "description": "behavior deemed inappropriate and a deviation from child's normal though parental observation obtained through follow-up phone call",
        "timeFrame": "up to 48 hours"
      },
      {
        "measure": "Delirium",
        "description": "Pediatric Anesthesia Emergence Delirium (PAED) score greater than 12 as defined by Sikich and Lerman. 0 = no delirium, 20 = worst possible delirium; 5 categories scored from 0-4 additive for a maximum score of 20. Categories 1-3 are scored the same and categories ar scored inversely as described. 1. Child makes contact with caregiver, 2. child's actions are purposeful, 3. child is aware of his surroundings. For each of these category, score 0 for extremely, 1 for very much, 2 for quite a bit, 3 for just a little, 4 for not at all. The other 2 categories 4. Child is restless and 5 Child is inconsolable are scored as 0 for not at all, 1 for just a little, 2 for quite a bit, 3 for very much, 4 for extremely",
        "timeFrame": "up to 24 hours."
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 12,
      "otherCount": 0,
      "totalCount": 13
    },
    "studyDesign": {
      "phases": [
        "PHASE4"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 99,
    "complexityCategory": "Highly Complex"
  },
  "collectionDate": "2025-09-22T02:29:50.542Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}